‘A mess across the board’: Senate committee kicks off talks on drug pricing reforms

The US is still the only country in the world that doesn’t negotiate pharmaceutical prices across the board, experts told a Senate committee on Tuesday, but how exactly to fix that remains unclear and few of the solutions discussed will surprise anyone watching the pricing debate play out over the last decade.